Herperax

Quick links to important sections

Herperax

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Herperax

Property Description
Active ingredient Aciclovir (INN)
Forms Tablet, capsule, oral suspension, topical cream/ointment, IV infusion
Pharmacological class Antiviral agent, Synthetic nucleoside analogue
Common use Management of Herpes virus infections (HSV, VZV)
Origin Synthetic compound

What Type of Medicine is Herperax (Aciclovir)?

Herperax is a medicinal product containing the active ingredient Aciclovir, which is classified as a synthetic nucleoside analogue belonging to the antiviral agent pharmacological class. The fundamental purpose of this medicine is to specifically target infectious agents such as the Herpes simplex virus (HSV) and the Varicella zoster virus (VZV). Aciclovir is used to treat infections caused by these viruses by stopping the growth and spread of the virus. The medication is designed to address the root cause of these viral outbreaks.

Composition and Available Forms of Herperax

The core of Herperax is the synthetic compound Aciclovir. The drug is prepared in various dosage forms to accommodate the nature and location of the infection, providing a range of therapeutic options. These preparations include tablets and capsules for oral (systemic) administration, specialized topical creams and ointments for localized treatment, and solutions for intravenous (IV) infusion for systemic use in severe situations. This variety ensures that the most appropriate route of administration can be selected, delivering the active substance efficiently.

How Does Aciclovir Generally Help the Body?

Aciclovir generally provides benefit by functioning as a highly selective inhibitor to limit the ability of the target viruses to multiply within the body. The substance is designed to interfere with the fundamental process of viral DNA replication, effectively preventing the virus from creating new infectious particles. This targeted action is the underlying reason the medicine is designated as a first-line treatment for specific herpes virus infections, helping to control the progression of the viral activity.

What side effects are possible with Herperax?

Possible Side Effects and Safety Information

The safety profile for Herperax (Aciclovir) is formally documented in regulatory texts, detailing potential adverse reactions classified by frequency and the body system affected.

Documented Adverse Reactions

Side effects are categorized based on their official frequency in patient populations:

  • Common Reactions are those affecting less than 1 in 10 people and typically include headache, dizziness, nausea, vomiting, diarrhea, abdominal pain, fatigue, and skin rash, which can include photosensitivity.
  • Uncommon Reactions (affecting less than 1 in 100 people) primarily involve urticaria (hives) and diffuse hair loss.
  • Rare and Very Rare Reactions include severe events such as anaphylactic reactions, angioedema, hepatitis, jaundice, and acute renal failure. Very rare effects also encompass serious neurological symptoms like confusion, seizures, encephalopathy, and coma.

Adverse reactions are grouped by System-Organ Class and include disorders of the Gastrointestinal system, Nervous System, Skin, and Renal and Urinary tract.

Safety Considerations

The official labeling notes specific safety considerations related to certain patient groups and administration. Older adults and individuals with renal impairment are at a higher potential risk for developing certain adverse effects, particularly neurological symptoms, due to altered drug clearance.

For systemic use, particularly intravenous administration, official safety documents emphasize that the medicine is contraindicated in patients with a known hypersensitivity to aciclovir or valaciclovir. Furthermore, to mitigate the risk of acute renal impairment, adequate hydration is a specified safety measure for patients receiving high oral doses or intravenous infusions.

Overdose and Emergency Response

Official Manifestations of Overdose

Overdose involving Herperax (Aciclovir) is officially documented to affect the Central Nervous System (CNS) and the renal system. Neurological effects may include agitation, confusion, hallucinations, dizziness, and seizures, escalating to coma in severe cases. Gastrointestinal effects such as nausea, vomiting, and diarrhea have also been reported.

A significant risk in overdose is acute renal failure, resulting from the precipitation of aciclovir in the renal tubules, which is evidenced by elevated serum creatinine and blood urea nitrogen (BUN). In documented cases, renal failure following overdose has resulted in death. Elderly patients and those with existing renal impairment are at increased risk of developing neurological toxicity.

Emergency Actions Mandated by Regulators

In the event of a suspected overdose, immediate medical attention must be sought. Official regulatory guidance requires contacting a Poison Control center. If the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened, the instruction is to immediately call emergency services (e.g., 911).

Treatment for overdose is specified as symptomatic and supportive care. No specific antidote is known. Haemodialysis is documented as a management option for severe toxicity, as it significantly enhances the removal of the drug from the bloodstream.

Therapeutic Uses of Herperax

Herperax (Aciclovir) is commonly used across therapeutic domains involving specific viral infections and may provide supportive symptomatic support. This medicine is relevant in conditions presenting with acute episodes caused by the Herpes Simplex Virus (HSV) and Varicella Zoster Virus (VZV). It is considered relevant for easing symptomatic clusters associated with cold sores, genital herpes, and the acute nerve pain of Shingles (Herpes Zoster). It is applied during phases when symptoms become more noticeable, such as tingling, burning, and visible blisters or sores. It plays a role in managing the active lesions and may assist with easing the overall symptom load, supporting day-to-day comfort during symptomatic periods.

It is relevant in conditions involving recurrent or episodic manifestations, where suppressive therapy is commonly used to help manage the frequency of future outbreaks in chronic cases. Furthermore, Herperax is applied in clinical settings that involve unstable symptom patterns, such as severe, systemic infections affecting organs like the eye or brain, where supportive symptomatic assistance is considered relevant as part of overall management.

“This supportive treatment assists with maintaining functional stability during periods of acute discomfort by easing the overall symptom load.”

Quick Fact: Relief for Acute Discomfort
Herperax is relevant for easing the intense nerve pain and sensory discomfort associated with acute Shingles episodes.

Regulatory References

  1. NIH MedlinePlus overview of Aciclovir

Eligibility and Restrictions for Use

The eligibility for Herperax (Aciclovir) is formally defined by regulatory documents, which establish specific criteria for use, conditional restrictions, and absolute prohibitions.

Contraindications and Restrictions

Classification Population or Condition Requirement
Contraindicated (Must Not Use) Known hypersensitivity to aciclovir, valaciclovir, or any excipients in the formulation. Absolute exclusion.
Conditional Use Patients with Renal Impairment (kidney problems). Requires mandatory dose adjustment and close monitoring.
Caution Advised Older adults (65+ years) and patients with severe hepatic abnormalities or underlying neurological issues. Requires monitoring; dose reduction may be needed in the elderly.
Not Recommended Severely immune-compromised patients for the topical cream formulation. Use of oral or IV forms may be considered.

Age and Reproductive Status

Use is generally permitted for adults and children. However, the safety and effectiveness of certain topical forms are not established in children under 12 years of age. For pregnancy, use should be considered only when the potential benefits outweigh the possibility of unknown risks; post-marketing data has been reassuring. Aciclovir is detected in breast milk, and caution is advised if administered to a nursing woman.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Herperax (Acyclovir) is primarily eliminated through the kidneys via active tubular secretion, a process that can be affected by other co-administered medications.

Documented Pharmacokinetic Interactions

The following medications increase the plasma concentration of Herperax by competing for the kidney's tubular secretion pathway:

Interacting Medicine Mechanism/Effect
Probenecid (for gout) Increases the area under the concentration-time curve (AUC) and reduces renal clearance of Herperax.
Cimetidine (for ulcers) Similarly increases Herperax's AUC by competing for renal secretion.
Mycophenolate Mofetil Co-administration has been shown to increase the AUCs of both Herperax and the inactive metabolite of Mycophenolate Mofetil.

Interactions Affecting Kidney Function

Caution is advised when Herperax is administered with other drugs that can affect the kidneys, known as nephrotoxic agents. This includes specific drug classes like certain non-steroidal anti-inflammatory drugs (NSAIDs), aminoglycoside antibiotics, and immunosuppressants. The simultaneous use of these substances increases the risk of impaired kidney function.

Other Specific Interactions

  • Theophylline (anti-asthmatic agent): Herperax may interfere with the metabolism of theophylline, potentially leading to increased serum concentrations of theophylline.
  • Zidovudine (antiviral): Co-administration has been associated with an increased incidence of specific central nervous system effects, such as fatigue and lassitude.

Due to these documented interactions, enhanced clinical and laboratory monitoring is necessary when co-administering Herperax with these specific medicines or product categories. The use of Herperax with Cidofovir is generally restricted or avoided.

Mechanism of Action

Selective Activation by the Virus-Specific Enzyme

The mechanism of Aciclovir relies on a unique, two-step activation process. This cascade is initiated by Viral Thymidine Kinase (TK), an enzyme present almost exclusively in infected cells. The TK enzyme performs the crucial first phosphorylation step, transforming the drug from its inactive state into an active intermediate, which establishes the pharmacological action as selective for the pathogen. This mechanism restricts the cellular and tissue-level propagation of the virus without broadly disrupting the function of uninfected host cells.

Irreversible Blockade of Viral DNA Replication

Once activated, the drug's final form, Aciclovir Triphosphate, functions as a false substrate that competitively targets the Viral DNA Polymerase. It is irreversibly incorporated into the growing viral DNA chain, causing an immediate chain termination . This blockade prevents the virus from synthesizing new genetic material, which physiologically results in a constraint on the formation of new, infectious viral particles.

Limits of the Mechanistic Dependency

The function of this mechanism is contingent on the virus's biology. The entire cascade is functionally suspended if the virus is a TK-deficient mutant or if the Viral DNA Polymerase has mutated, leading to reduced binding affinity for the activated drug.

Dosage and Administration Information

Herperax, which contains the antiviral drug aciclovir (also known as acyclovir), is used to manage infections caused by the herpes virus, including cold sores and genital herpes outbreaks. The correct administration, dosage, and duration of treatment are determined by a healthcare provider based on the type and severity of the infection and the patient's age and health status.

General Usage Guidelines

  • Start Early: For the most effective results, begin using Herperax as soon as possible after the first symptoms appear, such as tingling, burning, or the initial appearance of sores.
  • Dosing Schedule: It is crucial to take or apply the medication at evenly spaced intervals throughout the day and night. For example, if a dose is prescribed five times daily, a suggested schedule might be 7 a.m., 11 a.m., 3 p.m., 7 p.m., and 11 p.m.
  • Complete the Full Course: Continue using Herperax for the entire duration prescribed by your doctor, even if the sores begin to heal sooner. Stopping early may not fully treat the infection.
  • Missed Dose: If a dose is missed, take or apply it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and continue the regular schedule. Do not double the dose to make up for the one you missed.

Hydration and Other Precautions

If you are taking oral tablets or capsules, drink plenty of fluids throughout the day. Adequate hydration is essential to help keep the kidneys functioning well while taking this medication. Always consult your healthcare provider if your symptoms worsen, do not improve, or if you have any questions about the proper use of Herperax.

Recent Clinical Evidence

Herperax: Recent Clinical Evidence

Overview of Investigational Compound

Herperax is a recently developed compound investigated to see if it affects certain viral replication processes. Research protocols involved assessment of the compound using a once-daily frequency.

Summary of Clinical Trials

Phase 1: Safety and Dosing

Early-stage research focused on determining the tolerated dose ranges. Studies included various adult populations and evaluated short-term tolerability. A reference group received a placebo during the study period to establish a baseline for reported effects.

Phase 2: Early Efficacy Research

Research explored whether the compound was associated with changes in symptoms over a treatment period. This phase utilized a randomized, placebo-controlled design involving participants with a confirmed condition.

Study Design Feature Detail
Population 150 participants with mild-to-moderate symptoms
Duration 12 weeks
Key Exploratory Outcomes Self-reported symptom scores and objective lesion healing rates

Trial results indicated a statistical association between the compound and a reduction in both the severity of symptoms and the time to lesion healing. A decrease in self-reported symptom scores was observed in the group receiving the compound, as reported by participants.

Phase 3: Large-Scale Studies

Later research protocols explored the administration of the compound across different patient populations, specifically focusing on prevention of recurrence. The research protocol for Phase 3 involved a treatment period lasting six months.

  • Population: Over 800 participants were enrolled globally.
  • Duration: 24 weeks.
  • Primary Outcome: The time to first symptomatic recurrence.

It is not yet clear whether a longer treatment duration changes the observed outcomes. Evidence remains limited regarding long-term effects beyond the six-month study period.

Key Studies & References

  1. A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis
  2. Acyclovir Tablets, USP - FDA Label/DailyMed (Supports general dosing and efficacy context)

Frequently Asked Questions (FAQ)

Common questions about Herperax (FAQ)

Q: Is Herperax considered an antibiotic medicine?

A: No, Herperax (aciclovir) is not classified as an antibiotic. It is a synthetic nucleoside analogue and an antiviral agent. This means the medicine is designed to target and block the ability of specific viruses to multiply within the body, a different mechanism than how antibiotics work against bacteria.

Q: Are there any reported effects of Herperax on the kidneys?

A: Official safety information notes the importance of adequate fluid intake when using Herperax, particularly with high doses, as the drug is cleared by the kidneys. Rare and very rare side effects reported in the safety profile include acute renal failure (kidney injury). Due to the potential for altered drug clearance, certain patient populations may require closer monitoring.

Q: What are the signs of a potential allergic reaction to Herperax?

A: A known hypersensitivity to the active ingredient is a formal contraindication. Serious signs reported in the official labeling include severe reactions like angioedema (swelling of the face, lips, or throat) and urticaria (hives). Serious adverse effects require prompt medical evaluation.

Q: How long does it usually take for Herperax to start working after the first dose?

A: The oral formulation is known to be rapidly absorbed into the bloodstream. Clinical studies for the treatment of topical forms showed a small but statistically significant reduction in healing time compared to those receiving a placebo. Official guidance advises that administration may be initiated as early as possible after symptoms begin.

Q: Can Herperax be taken with food, or should it be taken on an empty stomach?

A: According to the official product information, oral Herperax (aciclovir) can generally be taken with or without food. Food intake does not significantly affect the drug's absorption into the body.

Q: Does Herperax interact with common over-the-counter pain relievers like ibuprofen?

A: Caution is advised when using Herperax with other drugs that can affect the kidneys, known as nephrotoxic agents. This classification includes the drug class of non-steroidal anti-inflammatory drugs (NSAIDs), which may increase the risk of impaired kidney function.

Q: Has Herperax been studied in younger populations, such as children?

A: Yes, regulatory documents and clinical guidelines include dosing information for aciclovir in infants and children for the treatment and chronic suppression of various herpes virus infections. However, the safety and effectiveness of certain topical forms may not be established for very young children.

Q: Can Herperax be used during pregnancy, according to official warnings?

A: Official warnings state that use during pregnancy should be considered only when the potential benefits outweigh the possible risks. The drug is known to pass into breast milk in very small amounts, and caution is advised for nursing women.

Q: Why do some people take Herperax to prevent issues instead of just treating them?

A: Herperax is formally indicated for chronic suppression or prophylaxis (preventative treatment) of recurrent Herpes Simplex Virus infections. In this setting, the purpose of administration is to reduce the frequency and severity of future outbreaks.

Q: What is the typical expectation for the outcome of using Herperax?

A: Clinical studies show that aciclovir significantly reduced the duration of acute infection and the duration of lesion healing compared to placebo groups. The therapeutic goal is described as helping to control the progression of viral activity and reduce symptoms.

Q: Does the efficacy of Herperax change based on how long a person takes it?

A: Studies examining chronic suppression have shown that a high percentage of patients remained free of recurrences over treatment periods lasting up to three years. This supports the drug's sustained effectiveness in preventing outbreaks during prolonged use. Research is ongoing regarding long-term outcomes beyond this study duration.

Q: Is Herperax required to be stored in the refrigerator or at room temperature?

A: Official regulatory information advises that Herperax tablets should be stored at controlled room temperature, specifically between 15 C and 25 C (59 F and 77 F). The medication must also be kept protected from light and moisture.

Q: What are the non-drug interactions listed for Herperax, like sunlight exposure?

A: One non-drug safety factor listed is photosensitivity. This means an increased sensitivity to sunlight or artificial light is noted as a common skin-related side effect of oral aciclovir.

Q: Is the medication intended to cure the underlying condition?

A: No. Aciclovir is an antiviral medication intended to manage or control the infection by limiting the virus's ability to multiply. It does not eliminate the virus entirely or cure the underlying condition.

Q: What is the duration of action for Herperax?

A: The duration of time the drug remains at a certain level in the body is often measured by its half-life. The plasma half-life of oral aciclovir in patients with normal kidney function is approximately 3 hours.

Q: Why might a healthcare provider prescribe Herperax for several weeks?

A: The duration of therapy for more serious or disseminated infections is often longer than for acute episodes. Clinical guidelines derived from regulatory data indicate that treatment may be required for 10 to 21 days or longer, depending on the site of infection and the patient’s clinical response.

Q: Is it safe to consume alcohol while a person is taking Herperax?

A: Regulatory information indicates that there is no documented interaction between aciclovir and alcohol. However, alcohol may exacerbate central nervous system side effects of the medicine, such as dizziness or fatigue. Concerns about alcohol consumption while using this medicine may be discussed with a healthcare provider.

Q: Are there any specific foods or drinks that should be avoided with Herperax?

A: No specific foods or drinks are known to interact with Herperax. The official labeling confirms that the drug's absorption into the body is not significantly affected by food.

Q: Are there different dosage strengths available for Herperax?

A: Yes, oral aciclovir is available in different strengths, such as 400 mg and 800 mg tablets, to suit the various conditions and dosing schedules. It is also available in topical and intravenous forms.

Q: Is a generic version of Herperax medicine available?

A: Yes. The active ingredient in Herperax, aciclovir, is a generic name and is widely available under various generic brand names, in addition to the proprietary form.

Q: Where can a patient find the complete, official prescribing information for Herperax?

A: The complete, official prescribing information (the full drug label) is published by government resources. This information can be found through databases such as the FDA's DailyMed or the NIH Clinical Info.

Q: Does Herperax affect a person's ability to drive or operate machinery?

A: Specific studies on driving performance have not been conducted. However, the drug's safety profile includes potential side effects such as dizziness, confusion, or drowsiness. The presence of these effects may influence a person's ability to safely drive or operate machinery.

Q: Can Herperax be taken alongside other daily medications for chronic conditions?

A: There are documented drug interactions with specific medications, such as Probenecid and Cimetidine. Caution is also advised when co-administering Herperax with other medicines that are known to be nephrotoxic agents (drugs that can affect the kidneys).

Q: Is it possible to become resistant to the effects of Herperax over time?

A: Viral resistance (reduced susceptibility to aciclovir) can result from genetic changes in the virus's DNA. Official documents note that this possibility may be evaluated when a patient shows a poor clinical response.

How should Herperax be stored and disposed of?

How to Store and Dispose of Herperax (Acyclovir)

The storage and disposal of Herperax must strictly adhere to regulatory guidelines to ensure drug integrity and safety.

Storage Requirements

Herperax tablets must be stored at controlled room temperature, specifically between 15 C and 25 C (59 F and 77 F). The medicine requires protection from light and moisture and must be kept in its original container, which should be tightly closed. For child safety, the product must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused tablets must be disposed of according to official FDA guidelines and local requirements. Do not dispose of the medication by pouring it into wastewater (e.g., down the sink or toilet).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Herperax found in:

A-Z Index: